Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025
The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...
Post Bulletin1d
Mayo Clinic plans $18M move of its Executive Health program
Mayo Clinic recently filed plans for the move of its Executive and Development Health Program, which cares for "ultra-high ...
‘It’s never too late’: LYMA Founder Lucy Goff on finding her purpose over age 50
Goff, who was honored on Forbes and Know Your Value’s “50 Over 50” global list, chats with MSNBC at the 30/50 Summit in Abu ...
BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings
A copy of the presentation materials can be accessed on the “Publication” section of the Company’s website at www.bioatla.com once the presentations have concluded.